Underexpression of miR-126-3p in Patients with Cholangiocarcinoma

OBJECTIVES: To evaluate the expression of miR-126-3p and its potential as a biomarker for cholangiocarcinoma (CCA) and to better understand the prognosis, comorbidities, and lifestyle habits associated with the disease. METHODS: Fifty-nine individuals were distributed into either the study group (38...

Descripción completa

Detalles Bibliográficos
Autores principales: Spinola, Lucas P, Vieira, Gabriel F, Fernandes-Ferreira, Rafael, Calastri, Maria CJ, Tenani, Graciele D, Aguiar, Franciana L, Boin, Ilka FSF, Costa, Larissa BE, Correia, Maria Fernanda C, Zanovelo, Eliane M, Souza, Daniele CB, Silva, Rita CMA, Silva, Renato F, Abrantes, Ana Margarida C, Botelho, Maria Filomena R R, Tralhão, José Guilherme L R, Souza, Dorotéia RS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190345/
https://www.ncbi.nlm.nih.gov/pubmed/33639676
http://dx.doi.org/10.31557/APJCP.2021.22.2.573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190345/
https://www.ncbi.nlm.nih.gov/pubmed/33639676
http://dx.doi.org/10.31557/APJCP.2021.22.2.573

Ejemplares similares